Literature DB >> 16139001

Chemoreduction in the management of retinoblastoma.

Jerry A Shields, Carol L Shields, Anna T Meadows.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16139001     DOI： 10.1016/j.ajo.2005.04.047

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  10 in total

1.  MRI helps depict clinically undetectable risk factors in advanced stage retinoblastomas.

Authors:  Paolo Galluzzi; Theodora Hadjistilianou; Alfonso Cerase; Paolo Toti; Sara Leonini; Sandra Bracco; Sonia de Francesco; Daniela Galimberti; Donatella Balducci; Pietro Piu; Lucia Monti; Matteo Bellini; Mauro Caini; Alessandro Rossi
Journal:  Neuroradiol J       Date:  2015-02

2.  Bilateral retinoblastoma: clinical presentation, management and treatment.

Authors:  Francesco Pichi; Andrea Lembo; Mariacarla De Luca; Theodora Hadjistilianou; Paolo Nucci
Journal:  Int Ophthalmol       Date:  2013-01-01       Impact factor: 2.031

3.  Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.

Authors:  Debra L Friedman; Mark Krailo; Doojduen Villaluna; Dan Gombos; Bryan Langholz; Rima Jubran; Carol Shields; Linn Murphree; Joan O'Brien; Sandra Kessel; Carlos Rodriguez-Galindo; Murali Chintagumpala; Anna T Meadows
Journal:  Pediatr Blood Cancer       Date:  2016-12-26       Impact factor: 3.167

4.  Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California.

Authors:  Dagny Zhu; Jesse L Berry; Lilangi Ediriwickrema; Kenneth Wong; Thomas C Lee; A Linn Murphree; Jonathan W Kim; Rima Jubran
Journal:  Ocul Oncol Pathol       Date:  2015-11-05

Review 5.  [Retinoblastoma].

Authors:  N Bornfeld; A Schüler; R Bölöni; C Jurklies; R Wieland; W Sauerwein; D Lohmann
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

6.  Preserving vision in retinoblastoma through early detection and intervention.

Authors:  Sidnei Epelman
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

7.  Efficacy of vincristine and carboplatin as chemo-reduction for advanced bilateral retinoblastoma, the Saudi experience.

Authors:  Amani Alkofide; Mouhab Ayas; Yasser Khafagah; Ashraf Rawashde; Mohamed Anas; Mary Barria; Khawar Siddiqui; Saleh Almesfer; Hind Alkatan
Journal:  Saudi J Ophthalmol       Date:  2013-07-19

8.  Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma.

Authors:  Lejla Mutapcic Vajzovic; Timothy G Murray; Mohammad A Aziz-Sultan; Amy C Schefler; Stacey Quintero Wolfe; Ditte Hess; Cristina E Fernandes; Sander R Dubovy
Journal:  Clin Ophthalmol       Date:  2011-02-10

9.  Intra-Arterial Chemotherapy as Primary Therapy for Retinoblastoma in Infants Less than 3 Months of Age: A Series of 10 Case-Studies.

Authors:  Miaojuan Chen; Junyang Zhao; Jiejun Xia; Zhenyin Liu; Hua Jiang; Gang Shen; Haibo Li; Yizhou Jiang; Jing Zhang
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

10.  Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.

Authors:  David H Abramson; Armida W M Fabius; Reda Issa; Jasmine H Francis; Brian P Marr; Ira J Dunkel; Y Pierre Gobin
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.